XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Statements of Financial Condition - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents (at cost $783,504,674 and $317,868,749, respectively) $ 783,504,674 $ 317,868,749
Equity in trading accounts:    
Cash and cash equivalents (at cost $250,962,623 and $241,622,902, respectively) 250,962,623 241,622,902
Unrealized gain (loss) on open commodity futures contracts 53,165,845 (144,765,937)
Unrealized gain (loss) on open swap contracts 29,567,013  
Receivable for shares sold 8,957,399 14,488,801
Dividends receivable 742,617 1,108,561
Interest receivable 3,380,138 334,804
Prepaid insurance [1] 132,854 16,624
ETF transaction fees receivable 2,000 1,000
Total Assets 1,130,415,163 430,675,504
Liabilities and Partners' Capital    
Payable for shares redeemed 8,957,399  
General Partner management fees payable 554,011 240,448
Professional fees payable 361,020 922,743
Brokerage commissions payable 171,877 160,052
Directors' fees payable [1] 22,034 8,056
License fees payable 29,672 5,729
Total Liabilities 10,096,013 1,337,028
Commitments and Contingencies
Partners' Capital    
General Partners 0 0
Limited Partners 1,120,319,150 429,338,476
Total Partners' Capital 1,120,319,150 429,338,476
Total Liabilities and Partners' Capital $ 1,130,415,163 $ 430,675,504
Limited Partners' shares outstanding 150,084,588 30,184,588
Net asset value per share $ 7.46 $ 14.22
Market value per share $ 7.42 $ 14.10
[1] Certain prior year amounts have been reclassified for consistency with the current presentation.